{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:42Z","timestamp":1793118282329,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":65,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41379-022-01113-8","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T02:02:36Z","timestamp":1655172156000},"page":"1551-1561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas"],"prefix":"10.1016","volume":"35","author":[{"given":"Sandra","family":"Ferreyra Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresia","family":"Kling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Olsson Bontell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir Store","family":"Jakola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8584-555X","authenticated-orcid":false,"given":"Helena","family":"Car\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01113-8_bib1","doi-asserted-by":"crossref","unstructured":"Ostrom Q, Patil N, Cioffi G, Waite K, Kruchko C & Barnholtz-Sloan J. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013\u20132017. Neuro Oncol. 22, iv1-iv96 (2020).","DOI":"10.1093\/neuonc\/noaa200"},{"key":"10.1038\/s41379-022-01113-8_bib2","doi-asserted-by":"crossref","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson M, Sahm F, Mawrin C, Weber D et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 23, 1821\u20131834 (2021).","DOI":"10.1093\/neuonc\/noab150"},{"key":"10.1038\/s41379-022-01113-8_bib3","doi-asserted-by":"crossref","unstructured":"Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn J, Minniti G et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat. Rev. Clin. Oncol. 18, 170\u2013186 (2021).","DOI":"10.1038\/s41571-020-00447-z"},{"key":"10.1038\/s41379-022-01113-8_bib4","doi-asserted-by":"crossref","unstructured":"Dagogo-Jack I & Shaw A. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","DOI":"10.1038\/nrclinonc.2017.166"},{"key":"10.1038\/s41379-022-01113-8_bib5","unstructured":"Ceccarelli M, Barthel F, Malta T, Sabedot T, Salama S, Murray B et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell164, 550\u2013563 (2016)."},{"key":"10.1038\/s41379-022-01113-8_bib6","doi-asserted-by":"crossref","unstructured":"Magill S, Vasudevan H, Seo K, Villanueva-Meyer J, Choudhury A, John Liu S et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nat. Commun. 11, 4803 (2020).","DOI":"10.1038\/s41467-020-18582-7"},{"key":"10.1038\/s41379-022-01113-8_bib7","doi-asserted-by":"crossref","unstructured":"Pfisterer W, Hank N, Preul M, Hendricks W, Pueschel J, Coons S et al. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neuro Oncol. 6, 290\u2013299 (2004).","DOI":"10.1215\/S1152851704000158"},{"key":"10.1038\/s41379-022-01113-8_bib8","doi-asserted-by":"crossref","unstructured":"Sottoriva A, Spiteri I, Piccirillo S, Touloumis A, Collins V, Marioni J et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. U. S. A. 110, 4009\u20134014 (2013).","DOI":"10.1073\/pnas.1219747110"},{"key":"10.1038\/s41379-022-01113-8_bib9","unstructured":"Sturm D, Witt H, Hovestadt V, Khuong-Quang D, Jones D, Konermann C et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell22, 425\u2013437 (2012)."},{"key":"10.1038\/s41379-022-01113-8_bib10","doi-asserted-by":"crossref","unstructured":"Network CGAR. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. New Engl. J. Med. 372, 2481\u20132498 (2015).","DOI":"10.1056\/NEJMoa1402121"},{"key":"10.1038\/s41379-022-01113-8_bib11","doi-asserted-by":"crossref","unstructured":"Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell17, 98\u2013110 (2010).","DOI":"10.1016\/j.ccr.2009.12.020"},{"key":"10.1038\/s41379-022-01113-8_bib12","doi-asserted-by":"crossref","unstructured":"Yan H, Parsons D, Jin G, McLendon R, Rasheed B, Yuan W et al. IDH1 and IDH2 mutations in gliomas. New Engl. J. Med. 360, 765\u2013773 (2009).","DOI":"10.1056\/NEJMoa0808710"},{"key":"10.1038\/s41379-022-01113-8_bib13","doi-asserted-by":"crossref","unstructured":"Nassiri F, Liu J, Patil V, Mamatjan Y, Wang J, Hugh-White R et al. A clinically applicable integrative molecular classification of meningiomas. Nature597, 119\u2013125 (2021).","DOI":"10.1038\/s41586-021-03850-3"},{"key":"10.1038\/s41379-022-01113-8_bib14","doi-asserted-by":"crossref","unstructured":"Jones P, Issa J & Baylin S. Targeting the cancer epigenome for therapy. Nat. Rev. Genet. 17, 630\u2013641 (2016).","DOI":"10.1038\/nrg.2016.93"},{"key":"10.1038\/s41379-022-01113-8_bib15","doi-asserted-by":"crossref","unstructured":"Baylin SB & Jones PA. Epigenetic Determinants of Cancer. Cold Spring Harb. Perspect. Biol. 8 (2016).","DOI":"10.1101\/cshperspect.a019505"},{"key":"10.1038\/s41379-022-01113-8_bib16","doi-asserted-by":"crossref","unstructured":"Danielsson A, Nemes S, Tisell M, Lannering B, Nordborg C, Sabel M et al. MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes. Clin. Epigenetics, 2015, Vol. 77 (2015).","DOI":"10.1186\/s13148-015-0103-3"},{"key":"10.1038\/s41379-022-01113-8_bib17","unstructured":"Capper D, Jones D, Sill M, Hovestadt V, Schrimpf D, Sturm D et al. DNA methylation-based classification of central nervous system tumours. Nature555, 469\u2013474 (2018)."},{"key":"10.1038\/s41379-022-01113-8_bib18","doi-asserted-by":"crossref","unstructured":"Sahm F, Schrimpf D, Stichel D, Jones D, Hielscher T, Schefzyk S et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 18, 682\u2013694 (2017).","DOI":"10.1016\/S1470-2045(17)30155-9"},{"key":"10.1038\/s41379-022-01113-8_bib19","doi-asserted-by":"crossref","unstructured":"Olar A, Wani K, Wilson C, Zadeh G, DeMonte F, Jones D et al. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol. 133, 431\u2013444 (2017).","DOI":"10.1007\/s00401-017-1678-x"},{"key":"10.1038\/s41379-022-01113-8_bib20","doi-asserted-by":"crossref","unstructured":"Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23, 1231\u20131251 (2021).","DOI":"10.1093\/neuonc\/noab106"},{"key":"10.1038\/s41379-022-01113-8_bib21","doi-asserted-by":"crossref","unstructured":"Jackson RJ, Fuller GN, Abi-Said D, Lang FF, Gokaslan ZL, Shi WM et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 3, 193\u2013200 (2001).","DOI":"10.1215\/S1522851701000011"},{"key":"10.1038\/s41379-022-01113-8_bib22","doi-asserted-by":"crossref","unstructured":"Wenger A, Ferreyra Vega S, Kling T, Olsson Bontell T, Jakola AS & Car\u00e9n H. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification. Neuro Oncol. 21, 616\u2013627 (2019).","DOI":"10.1093\/neuonc\/noz011"},{"key":"10.1038\/s41379-022-01113-8_bib23","doi-asserted-by":"crossref","unstructured":"Jaffe A & Irizarry R. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 15, R31 (2014).","DOI":"10.1186\/gb-2014-15-2-r31"},{"key":"10.1038\/s41379-022-01113-8_bib24","doi-asserted-by":"crossref","unstructured":"Aran D, Sirota M & Butte A. Systematic pan-cancer analysis of tumour purity. Nat. Commun. 6, 8971 (2015).","DOI":"10.1038\/ncomms9971"},{"key":"10.1038\/s41379-022-01113-8_bib25","doi-asserted-by":"crossref","unstructured":"Zheng X, Zhang N, Wu H & Wu H. Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies. Genome Biol. 18, 17 (2017).","DOI":"10.1186\/s13059-016-1143-5"},{"key":"10.1038\/s41379-022-01113-8_bib26","doi-asserted-by":"crossref","unstructured":"Qin Y, Feng H, Chen M, Wu H & Zheng X. InfiniumPurify: An R package for estimating and accounting for tumor purity in cancer methylation research. Genes & diseases5, 43\u201345 (2018).","DOI":"10.1016\/j.gendis.2018.02.003"},{"key":"10.1038\/s41379-022-01113-8_bib27","doi-asserted-by":"crossref","unstructured":"Benelli M, Romagnoli D & Demichelis F. Tumor purity quantification by clonal DNA methylation signatures. Bioinformatics34, 1642\u20131649 (2018).","DOI":"10.1093\/bioinformatics\/bty011"},{"key":"10.1038\/s41379-022-01113-8_bib28","doi-asserted-by":"crossref","unstructured":"Johann P, Jager N, Pfister S & Sill M. RF_Purify: a novel tool for comprehensive analysis of tumor-purity in methylation array data based on random forest regression. BMC Bioinformatics20, 428 (2019).","DOI":"10.1186\/s12859-019-3014-z"},{"key":"10.1038\/s41379-022-01113-8_bib29","doi-asserted-by":"crossref","unstructured":"Zheng X, Zhao Q, Wu H, Li W, Wang H, Meyer C et al. MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomes. Genome Biol. 15, 419 (2014).","DOI":"10.1186\/PREACCEPT-9737754001327268"},{"key":"10.1038\/s41379-022-01113-8_bib30","doi-asserted-by":"crossref","unstructured":"Bady P, Delorenzi M & Hegi ME. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors. J. Mol. Diagn. 18, 350\u2013361 (2016).","DOI":"10.1016\/j.jmoldx.2015.11.009"},{"key":"10.1038\/s41379-022-01113-8_bib31","doi-asserted-by":"crossref","unstructured":"Bady P, Sciuscio D, Diserens A-C, Bloch J, den Bent M, Marosi C et al. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol. 124, 547\u2013560 (2012).","DOI":"10.1007\/s00401-012-1016-2"},{"key":"10.1038\/s41379-022-01113-8_bib32","doi-asserted-by":"crossref","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).","DOI":"10.1186\/gb-2013-14-10-r115"},{"key":"10.1038\/s41379-022-01113-8_bib33","doi-asserted-by":"crossref","unstructured":"Ferreyra Vega S, Olsson Bontell T, Corell A, Smits A, Jakola AS & Car\u00e9n H. DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas. Clin. Epigenetics13, 102 (2021).","DOI":"10.1186\/s13148-021-01085-7"},{"key":"10.1038\/s41379-022-01113-8_bib34","unstructured":"Malta T, Sokolov A, Gentles A, Burzykowski T, Poisson L, Weinstein J et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell173, 338\u2013354 e315 (2018)."},{"key":"10.1038\/s41379-022-01113-8_bib35","doi-asserted-by":"crossref","unstructured":"Molecular neuropathology. Brain classifier 12.5, https:\/\/www.molecularneuropathology.org\/mnp (2022).","DOI":"10.3390\/brainsci12020257"},{"key":"10.1038\/s41379-022-01113-8_bib36","doi-asserted-by":"crossref","unstructured":"Capper D, Stichel D, Sahm F, Jones D, Schrimpf D, Sill M et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 136, 181\u2013210 (2018).","DOI":"10.1007\/s00401-018-1879-y"},{"key":"10.1038\/s41379-022-01113-8_bib37","doi-asserted-by":"crossref","unstructured":"Maas S, Stichel D, Hielscher T, Sievers P, Berghoff A, Schrimpf D et al. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. J. Clin. Oncol. 39, 3839\u20133852 (2021).","DOI":"10.1200\/JCO.21.00784"},{"key":"10.1038\/s41379-022-01113-8_bib38","unstructured":"Therneau T. A Package for Survival Analysis in R, R package version 3.2\u20133, https:\/\/CRAN.R-project.org\/package=survival (2021)"},{"key":"10.1038\/s41379-022-01113-8_bib39","unstructured":"Wei T & Simo V. R package \u2018corrplot': Visualization of a Correlation Matrix, R package version 0.84, https:\/\/github.com\/taiyun\/corrplot (2021)"},{"key":"10.1038\/s41379-022-01113-8_bib40","unstructured":"Harrell JF. Harrell Miscellaneous, R package version 4.4\u20131, https:\/\/CRAN.R-project.org\/package=Hmisc (2021)"},{"key":"10.1038\/s41379-022-01113-8_bib41","doi-asserted-by":"crossref","unstructured":"de Souza C, Sabedot T, Malta T, Stetson L, Morozova O, Sokolov A et al. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence. Cell Rep. 23, 637\u2013651 (2018).","DOI":"10.1016\/j.celrep.2018.03.107"},{"key":"10.1038\/s41379-022-01113-8_bib42","doi-asserted-by":"crossref","unstructured":"Millesi M, Ryba AS, Hainfellner JA, Roetzer T, Berghoff AS, Preusser M. et al. DNA Methylation associates with clinical courses of atypical meningiomas: A matched case-control study. Front. Oncol., 603, 811729, (2022).","DOI":"10.3389\/fonc.2022.811729"},{"key":"10.1038\/s41379-022-01113-8_bib43","doi-asserted-by":"crossref","unstructured":"Zhou W, Triche T, Jr., Laird P & Shen H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 46, e123 (2018).","DOI":"10.1093\/nar\/gky691"},{"key":"10.1038\/s41379-022-01113-8_bib44","doi-asserted-by":"crossref","unstructured":"Kling T, Wenger A & Car\u00e9n H. DNA methylation-based age estimation in pediatric healthy tissues and brain tumors. Aging (Albany N. Y.)12, 21037\u201321056 (2020).","DOI":"10.18632\/aging.202145"},{"key":"10.1038\/s41379-022-01113-8_bib45","doi-asserted-by":"crossref","unstructured":"Liao P, Ostrom Q, Stetson L & Barnholtz-Sloan J. Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence. Neuro Oncol. 20, 942\u2013953 (2018).","DOI":"10.1093\/neuonc\/noy003"},{"key":"10.1038\/s41379-022-01113-8_bib46","doi-asserted-by":"crossref","unstructured":"Zheng S, Widschwendter M & Teschendorff A. Epigenetic drift, epigenetic clocks and cancer risk. Epigenomics8, 705\u2013719 (2016).","DOI":"10.2217\/epi-2015-0017"},{"key":"10.1038\/s41379-022-01113-8_bib47","doi-asserted-by":"crossref","unstructured":"Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Eng. J. Med. 352, 997 (2005).","DOI":"10.1056\/NEJMoa043331"},{"key":"10.1038\/s41379-022-01113-8_bib48","doi-asserted-by":"crossref","unstructured":"Malmstrom A, Gronberg B, Marosi C, Stupp R, Frappaz D, Schultz H et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 13, 916\u2013926 (2012).","DOI":"10.1016\/S1470-2045(12)70265-6"},{"key":"10.1038\/s41379-022-01113-8_bib49","doi-asserted-by":"crossref","unstructured":"Bell E, Zhang P, Fisher B, Macdonald D, McElroy J, Lesser G et al. Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide An Analysis From the NRG Oncology\/RTOG 0424 Trial. Jama Oncology4, 1405\u20131409 (2018).","DOI":"10.1001\/jamaoncol.2018.1977"},{"key":"10.1038\/s41379-022-01113-8_bib50","doi-asserted-by":"crossref","unstructured":"Weber R, Bostrom J, Wolter M, Baudis M, Collins V, Reifenberger G et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc. Natl. Acad. Sci. U. S. A. 94, 14719\u201314724 (1997).","DOI":"10.1073\/pnas.94.26.14719"},{"key":"10.1038\/s41379-022-01113-8_bib51","doi-asserted-by":"crossref","unstructured":"Wylleman R, Debiec-Rychter M & Sciot R. A rare case of atypical\/anaplastic meningioma with MDM2 amplification. Rare Tumors10, 2036361318779511 (2018).","DOI":"10.1177\/2036361318779511"},{"key":"10.1038\/s41379-022-01113-8_bib52","doi-asserted-by":"crossref","unstructured":"Verburg N, Barthel F, Anderson K, Johnson K, Koopman T, Yaqub M et al. Spatial concordance of DNA methylation classification in diffuse glioma. Neuro Oncol. 23, 2054\u20132065 (2021).","DOI":"10.1093\/neuonc\/noab134"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01113-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01113-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01113-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:38:52Z","timestamp":1760229532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0893395222002216"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01113-8","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01113-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}